Video
Dr. Sorensen investigates ultrasound treatment in patients with kidney stones
Author(s):
"This particular study comes from our human randomized trial that we hope will be the final step before FDA approval for the technology,” says Mathew D. Sorensen, MD, MS, FACS.
Video Player is loading.
In this video, Mathew D. Sorensen, MD, MS, FACS, discusses the background and learning curve of ultrasonic propulsion stone treatment, from the study, “Randomized control trial of ultrasonic propulsion to facilitate clearance of chronic residual fragments,” presented recently at the 2021 American Urological Association Annual Meeting. Sorensen is an associate professor and residency program director of the department of urology at the University of Washington, Seattle, Washington.
Related Videos
5 key trial insights from AUA 2025
Félix Guerrero-Ramos, MD, on TAR-200 in papillary disease-only NMIBC
Khurshid Ghani, MD, on trial of stent omission following ureteroscopy
Shreyas Joshi, MD, recaps AUA session on chemotherapy vs novel NMIBC options
Shay Rajavel, MS3, on CO2 gas embolism during single-port partial nephrectomy
Kevin Zorn, MD, on preserving ejaculation with BPH therapies
Neal Shore, MD, on sasanlimab plus BCG for BCG-naïve NMIBC
Alexander Glaser, MD, on real-world outcomes with Aquablation
Vitaly Margulis, MD, on preliminary safety, efficacy of padeliporfin VTP for UTUC
Joseph Jacob, MD, on the durability of TAR-200 in NMIBC
Related Content
